Your browser doesn't support javascript.
loading
Re: Neoadjuvant chemotherapy for advanced ovarian cancer. Who really benefits?
Pather, Selvan; Tejada Berges, Trevor; Saidi, Sam; Carter, Jonathan.
Afiliação
  • Pather S; The Sydney Gynaecologic Group, Chris O Brien Lifehouse, Camperdown, New South Wales, Australia.
  • Tejada Berges T; Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia.
  • Saidi S; The Sydney Gynaecologic Group, Chris O Brien Lifehouse, Camperdown, New South Wales, Australia.
  • Carter J; Royal Prince Alfred Hospital and University of Sydney, Sydney, New South Wales, Australia.
Aust N Z J Obstet Gynaecol ; 58(6): E25-E26, 2018 12.
Article em En | MEDLINE | ID: mdl-30536512
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma Epitelial do Ovário Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Carcinoma Epitelial do Ovário Limite: Female / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article